Barrett's esophagus: Genetic and cell changes

Annals of the New York Academy of Sciences

Volumn 1232, Issue 1, 2011, Pages 18-35

  Souza, Rhonda F ^a   Freschi, Giancarlo ^b   Taddei, Antonio ^b   Ringressi, Maria Novella ^b   Bechi, Paolo ^b   Castiglione, Francesca ^c   Degl'Innocenti, Duccio Rossi ^c   Triadafilopoulos, George ^d   Wang, Jean S ^e   Chang, Andrew C ^f   Barr, Hugh ^g   Bajpai, Manisha ^h   Das, Kiron M ^h   Schneider, Paul M ⁱ   Krishnadath, Kausilia K ^j   Malhotra, Usha ^k   Lynch, John P ^l  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Department of Medical and Surgical Critical Care Unit of Surgery ^*  (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g CRANFIELD UNIVERSITY   (United Kingdom)

^h ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^j ACADEMIC MEDICAL CENTER   (Netherlands)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Adenocarcinoma; BAR T cells; Barrett's esophagus; Bile; BMP 4; CDKN2A; CDX 1gene; CDX 2 gene; Hedgehog pathway; Hox genes; IGF 1R genotype; Intestinal metaplasia; MAb Das 1; Mitogen activated protein kinase; NF B; P16; P53; TP53; Villin

Indexed keywords

BILE ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH RECEPTOR; PROTEIN P16; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR RUVB1; TRANSCRIPTION FACTOR RUVB2; TUMOR MARKER; UNCLASSIFIED DRUG; WNT PROTEIN;

ANEUPLOIDY; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CLONAL VARIATION; CYTOLOGY; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; GENETIC ANALYSIS; HOMEOBOX; HUMAN; METAPLASIA; METHYLATION; NEOPLASM; NONHUMAN; PATHOGENESIS; PHENOTYPE; TETRAPLOIDY; TUMOR GROWTH;

ERINACEIDAE;

EID: 80053207315     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06043.x     Document Type: Article

References (63)

1. Ronkainen, J., P. Aro, T. Storskrubb, et al 2005. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129: 1825-1831.
2. Chak, A., H. Ochs-Balcom, G. Falk, et al 2006. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastresophageal junction Cancer Epidemiol. Biomarkers Prev. 15: 1668-1673.
3. Trudgill, N.J., K.C. Kapur & S.A. Riley 1999. Familial clustering of reflux symptoms. Am. J. Gastroenterol. 94: 1172-1178.
4. Moons, L.M., J.G. Kusters, J.H. Van Delft, et al 2008. A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis 29: 926-931.
5. Macdonald, K., G.A. Porter, D.L. Guernsey, et al 2009. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma. Cancer Epidemiol. 33: 37-40.
6. Souza, R.F., K. Krishnan & S.J. Spechler 2008. Acid, Bile and CDX: the ABCs of making Barrett's metaplasia. Am. J. Physiol. Gastrointest. Liver Physiol. 295: 211-218.
7. Fitzgerald, R.C. 2006. Molecular basis of Barrett's esophagus and esophageal adenocarcinoma. Gut. 55: 1810-1820.
8. Kazumori, H., S. Ishihara & Y. Kinoshita 2009. Roles of caudal-related homeobox gene Cdx1 in esophageal epithelial cells in Barrett's epithelium development. Gut. 58: 620-628.
9. Peters, J.H. & N. Avisar 2010. The molecular pathogenesis of Barrett's esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia. J. Gastroint. Surg. 14(Suppl 1): S81-S87.
10. Vaninetti, N., L. Williams, L. Geldenhuys, et al 2009.Regulation of CDX2 expression in esophageal adenocarcinoma. Mol. Carcinog. 48: 965-974.
11. Souza, R.F., K. Shewmake, L.S. Terada & S.J. Spechler 2002. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122: 299-307.
12. Fitzgerald, R.C., M.B. Omary, G. Triadafilopoulos 1996. Dynamic effects of acid on Barrett's esophagus. Anex vivoproliferation and differentiation model. J. Clin. Invest. 98: 2120-2128.
13. Saadi, A., N.B. Shannon, P. Lao-Sirieix, et al. 2010. Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc. Natl. Acad. Sci. U. S. A. 107: 2177-2182.
14. Lu, S., A.W. Lowe, G. Triadafilopoulos, et al. 2009. Endoscopic evaluation of esophago-gastro-jejunostomy in rat model of Barrett's esophagus. Dis. Esophagus. 22: 323-330.
15. Merlo, L.M., L.S. Wang, J.W. Pepper, et al. 2010. Polyploidy, aneuploidy and the evolution of cancer. Adv. Exp. Med. Biol. 676: 1-13.
16. Leedham, S.J., S.L. Preston, S.A. Mcdonald, et al. 2008. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's esophagus. Gut. 57: 1041-1048.
17. Boonstra, J.J., R. Van Marion, D.G. Beer, et al 2010. Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J. Natl. Cancer Inst. 102: 271-274.
18. Jaiswal, K.R., C.P. Morales, L.A. Feagins, et al 2007. Characterization of telomerase- immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis. Esophagus 20: 256-264.
19. Palanca-Wessels, M.C., A. Klingelhutz, B.J. Reid, et al 2003. Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 24: 1183-1190.
20. Maley, C.C., P.C. Galipeau, J.C. Finley, et al 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38: 468-473.
21. Okawa, T, C.Z. Michaylira, J. Kalabis, et al 2007. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes. Dev. 21: 2788-2803.
22. Merlo, L.M., N.A. Shah, X. Li, et al. 2010. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev. Res. 3: 1388-1397.
23. Michor, F. & K. Polyak 2010. The origins and implications of intratumor heterogeneity. Cancer Prev. Res. 3: 1361-1364.
24. Barbera, M. & R.C. Fitzgerald 2010. Cellular origin of Barrett's metaplasia and esophageal stem cells. Biochem. Soc. Trans. 38: 370-373.
25. Nowell, P.C. 1976. The clonal evolution of tumor cell populations. Science 194: 238.
26. Maley, C.C., P.C. Galipeau, J.C. Finley, et al 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38: 468-473.
27. Leedham, S.J., S.L. Preston, S.A.C. Mcdonald, et al 2008. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's esophagus. Gut 57: 1041-1048.
28. Wright, N.A. Migration of the ductular elements of Gut-associated glands gives clues to the histogenesis of structures associated with responses to acid hypersecretory state: The origins of "gastric metaplasia in the duodenum of specialised mucosa of Barrett's esophagus and pseudopyloric metaplasia. Yale J. Biol. Med. 69: 147-153.
29. Fitzgerald, R.C. 2008. Dissecting out the genetic origins of Barrett's esophagus. Gut 57: 1033-1034.
30. Maley, C.C., P.C. Galipeau, X. Li, et al. 2004. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 64: 7629-7633.
31. Leedham, S.J., S.L. Preston, S.A.C. Mcdonald, et al 2008. Individual crypt genetic heterogeneity and origin of metaplastic glandular epithelium in human Barrett' esophagus. Gut 57: 1041-1048.
32. Coad, R.A., A.C. Woodman, P.J. Warner, et al 2005. On the histiogenesis of Barrett's esophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native esophageal gland ducts. J. Pathol. 25: 388-394.
33. Jaiswal, K.R., C.P. Morales, L.A. Feagins, et al 2007. Characterization of telomerase- immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis. Esophagus. 20: 256-264.
34. Mirza, Z.K., K.K. Das, J. Slate, et al. 2003. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut. 52: 807-812.
35. Das, K.M., I. Prasad, S. Garla & P.S. Amenta Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann. Intern. Med. 120: 753-756.
36. Bajpai, M., J. Liu, X. Geng, et al 2008. Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line. Lab Invest 88: 643-651.
37. Das, K.M., Y. Kong, M. Bajpai, et al 2010. Transformation of benign barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in-vitro model. Int. J. Cancer. 22.
38. Xi, H., S.E. Baldus, U. Warnecke-Eberz, et al 2005. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Clin. Cancer Res. 11: 8341-8347.
39. Luthra, R, T.T. Wu, M.G. Luthra, et al 2006. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J. Clin. Oncol. 24: 259-267.
40. Lurje, G., J.M. Leers, A. Pohl, et al 2010. Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus. Ann. Surg. 251: 857-864.
41. Peng, D., E.A. Sheta, S.M. Powell, et al 2008. Alterations in Barrett's-related adenocarcinomas: a proteomic approach. Int. J. Cancer 122: 1303-1310.
42. de Godoy, L.M., J.V. Olsen, J. Cox, et al 2008. Comprehensive mass- spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455: 1251-1254.
43. Kazumori, H., S. Ishihara, M.A. Rumi, et al. 2006. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut. 55: 16-25.
44. Huo, X., H.Y. Zhang, X.I. Zhang, et al Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. Gastroenterology 139: 194-203 e191.
45. Kazumori, H., S. Ishihara & Y. Kinoshita 2009. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut. 58: 620-628.
46. Stairs, D.B., H. Nakagawa, A. Klein-Szanto, et al 2008. Cdx1 and c- Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. PLoS One 3: e3534.
47. Wang, D.H., N.J. Clemons, T. Miyashita, et al. Aberrant epithelial- mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 138: 1810-1822.
48. van Baal, J.W., F. Milano, A. Rygiel, et al 2005. A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 129: 1274-1281.
49. Milano, F., J.W. Van Baal, N.S. Buttar, et al. 2007. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 132: 2412-2421.
50. Jaiswal, K.R., C.P. Morales, L.A. Feagins, et al 2007. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T) Dis. Esophagus. 20: 256-264.
51. Hong, J., M. Resnick, J. Behar, et al 2010. Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G697-G706.
52. Fitzgerald, R.C., M.B. Omary & G. Triadafilopoulos 1996. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J. Clin. Invest. 98: 2120-2128.
53. Zhang, H.Y., X. Zhang, K. Hormi-Carver, et al 2007. In Non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway. Cancer Res. 67: 8580-8587.
54. Dvorakova, K., C.M. Payne, L. Ramsey, et al 2005. Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am. J. Gastroenterol. 100: 424-431.
55. Pepe, M.S., R. Etzioni, Z. Feng, et al 2001. Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 93: 1054-1061.
56. Rabinovitch, P.S., G. Longton, P.L. Blount, et al 2001. Predictors of progression in Barrett's esophagus: baseline flow cytometric variables. Am. J. Gastroenterol. 96: 3071-3083.
57. Reid, B.J., L.J. Prevo, P.C. Agalipeau, et al 2001. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am. J. Gastroenterol. 96: 2839-2848.
58. Maley, C.C., P.C. Galipeau, X. Li, et al 2004. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 64: 7629-7633.
59. Stairs, D.B., J. Kong, & J.P. Lynch, Cdx genes, inflammation, and the pathogenesis of intestinal metaplasias, In Molecular Biology of Digestive Organs. K. Kaestner, Ed. In Press, Elsevier .
60. Hormi-Carver, K. & R.F. Souza 2009. Molecular markers and genetics in cancer development. Surg. Oncol. Clin. N. Am. 18: 453-467.
61. Farnebo, M., V.J. Bykov, & K.G. Wiman 2010. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem. Biophys. Res. Commun. 396: 85-89.
62. Hanahan, D. & R.A. Weinberg 2000. The hallmarks of cancer. Cell 100: 57-70.
63. Prasad, G.A., et al Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am. J. Gastroenterol. 105: 1490-1502.